Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 400, pseudogene (RN7SL400P)

Target
RN7SL400P
Molecular classification
Other (Pseudogene, noncoding RNA pseudogene)
01

Overview

RN7SL400P is a pseudogene of the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex essential for the targeting of secretory and membrane proteins to the endoplasmic reticulum in eukaryotes. The canonical 7SL RNA is an abundant noncoding RNA with important architectural and regulatory roles in SRP function, translation arrest, and possibly stress responses[1][3]. In contrast, RN7SL400P refers specifically to a pseudogene—a genomic DNA segment similar to the functional 7SL RNA gene but presumed nonfunctional due to sequence truncation, mutation, or lack of transcription[5][7]. Most 7SL-related pseudogenes, like RN7SL400P, are not transcribed into RNA, do not produce protein, and have no direct, established roles in cellular function or disease[5][7]. Pseudogenes of 7SL RNA, common throughout the human genome, are typically evolutionary remnants resulting from retrotransposition or duplication events[5][7]. In rare cases, some pseudogenes can give rise to small regulatory RNAs or potentially influence gene expression epigenetically, but there is no evidence that RN7SL400P itself serves such a role[4][6]. RN7SL400P is not considered a therapeutic target, nor is it implicated in any disease or current pharmacological modulation. There is something incorrect about listing RN7SL400P as a therapeutic target: it is a pseudogene, not a functional gene, receptor, or protein, and does not encode a receptor, enzyme, transporter, or any molecule typically considered a drug target[5][7].

Other names
RN7SL400P
02

Biological functions

Other (No known biological function; noncoding pseudogene)
03

Disease associations

Other (No established disease role)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 400, pseudogene (RN7SL400P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 400, pseudogene (RN7SL400P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call